{"id":5372,"date":"2011-07-22T17:00:16","date_gmt":"2011-07-22T17:00:16","guid":{"rendered":"An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC\u2019s Institute for Drug Development through its Phase I clinical research program. Phase I studies offer hope for cancer patients through new investigational anti"},"modified":"2016-04-03T20:05:03","modified_gmt":"2016-04-03T20:05:03","slug":"500000-to-support-phase-i-clinical-drug-programs","status":"publish","type":"post","link":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/","title":{"rendered":"$500,000 to support Phase I clinical drug programs"},"content":{"rendered":"<p>An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC\u2019s Institute for Drug Development through its Phase I clinical research program. Phase I studies offer hope for cancer patients through new investigational anticancer drugs or new combinations of novel therapies. This generous gift will support researchers who study the molecular characteristics of tumors and monitor how these relate to patients\u2019 responses. It will also fund pharmacogenomic studies that show how genes affect a person\u2019s response to drugs. In addition to funding a biorepository that collects tissues to facilitate studies to optimize personalized cancer therapies, this gift will provide support for novel clinical trials designed and conducted by CTRC clinicians, as well as translational studies to identify new drug targets and approaches for optimal cancer treatments.<\/p>\n<p><i><span style=\"font-size: xx-small;\">The Cancer Therapy &amp; Research Center (CTRC) at the UT Health Science Center San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC\u2019s Institute for Drug Development [&hellip;]<\/p>\n","protected":false},"author":23,"featured_media":3446,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[150],"tags":[],"ppma_author":[282],"class_list":["post-5372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fall-2011"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$500,000 to support Phase I clinical drug programs - Mission Magazine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$500,000 to support Phase I clinical drug programs - Mission Magazine\" \/>\n<meta property=\"og:description\" content=\"An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC\u2019s Institute for Drug Development [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/\" \/>\n<meta property=\"og:site_name\" content=\"Mission Magazine\" \/>\n<meta property=\"article:published_time\" content=\"2011-07-22T17:00:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-04-03T20:05:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"665\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"contributor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"contributor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/\"},\"author\":{\"name\":\"contributor\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/person\\\/ffb145426f57a0322ba63b1cd767873e\"},\"headline\":\"$500,000 to support Phase I clinical drug programs\",\"datePublished\":\"2011-07-22T17:00:16+00:00\",\"dateModified\":\"2016-04-03T20:05:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2015\\\/06\\\/monument_H_DSC_058.jpg\",\"articleSection\":[\"Fall 2011\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/\",\"name\":\"$500,000 to support Phase I clinical drug programs - Mission Magazine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2015\\\/06\\\/monument_H_DSC_058.jpg\",\"datePublished\":\"2011-07-22T17:00:16+00:00\",\"dateModified\":\"2016-04-03T20:05:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2015\\\/06\\\/monument_H_DSC_058.jpg\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2015\\\/06\\\/monument_H_DSC_058.jpg\",\"width\":1000,\"height\":665,\"caption\":\"UT Health Science Center at San Antonio, uthscsa, monument\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/500000-to-support-phase-i-clinical-drug-programs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$500,000 to support Phase I clinical drug programs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#website\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\",\"name\":\"Mission Magazine\",\"description\":\"The University of Texas Health Science Center at San Antonio Mission magazine\",\"publisher\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#organization\",\"name\":\"Mission Magazine\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2024\\\/10\\\/UTHSA_logo_H_CMYK-350.jpg\",\"contentUrl\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/wp-content\\\/uploads\\\/sites\\\/20\\\/2024\\\/10\\\/UTHSA_logo_H_CMYK-350.jpg\",\"width\":350,\"height\":121,\"caption\":\"Mission Magazine\"},\"image\":{\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/#\\\/schema\\\/person\\\/ffb145426f57a0322ba63b1cd767873e\",\"name\":\"contributor\",\"url\":\"https:\\\/\\\/magazines.uthscsa.edu\\\/mission\\\/author\\\/communications\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$500,000 to support Phase I clinical drug programs - Mission Magazine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/","og_locale":"en_US","og_type":"article","og_title":"$500,000 to support Phase I clinical drug programs - Mission Magazine","og_description":"An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC\u2019s Institute for Drug Development [&hellip;]","og_url":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/","og_site_name":"Mission Magazine","article_published_time":"2011-07-22T17:00:16+00:00","article_modified_time":"2016-04-03T20:05:03+00:00","og_image":[{"width":1000,"height":665,"url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg","type":"image\/jpeg"}],"author":"contributor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"contributor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#article","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/"},"author":{"name":"contributor","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/ffb145426f57a0322ba63b1cd767873e"},"headline":"$500,000 to support Phase I clinical drug programs","datePublished":"2011-07-22T17:00:16+00:00","dateModified":"2016-04-03T20:05:03+00:00","mainEntityOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg","articleSection":["Fall 2011"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/","name":"$500,000 to support Phase I clinical drug programs - Mission Magazine","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#primaryimage"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg","datePublished":"2011-07-22T17:00:16+00:00","dateModified":"2016-04-03T20:05:03+00:00","breadcrumb":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#primaryimage","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2015\/06\/monument_H_DSC_058.jpg","width":1000,"height":665,"caption":"UT Health Science Center at San Antonio, uthscsa, monument"},{"@type":"BreadcrumbList","@id":"https:\/\/magazines.uthscsa.edu\/mission\/500000-to-support-phase-i-clinical-drug-programs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magazines.uthscsa.edu\/mission\/"},{"@type":"ListItem","position":2,"name":"$500,000 to support Phase I clinical drug programs"}]},{"@type":"WebSite","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website","url":"https:\/\/magazines.uthscsa.edu\/mission\/","name":"Mission Magazine","description":"The University of Texas Health Science Center at San Antonio Mission magazine","publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magazines.uthscsa.edu\/mission\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization","name":"Mission Magazine","url":"https:\/\/magazines.uthscsa.edu\/mission\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","width":350,"height":121,"caption":"Mission Magazine"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/ffb145426f57a0322ba63b1cd767873e","name":"contributor","url":"https:\/\/magazines.uthscsa.edu\/mission\/author\/communications\/"}]}},"authors":[{"term_id":282,"user_id":23,"is_guest":0,"slug":"communications","display_name":"contributor","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/fe5d595b1ed682963b6a3444e8d8fb1d5d728dd56bd10b167f41c3ced488a8e7?s=96&d=mm&r=g","author_category":"","first_name":"UTHSCSA","last_name":"contributor","user_url":"","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/5372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/comments?post=5372"}],"version-history":[{"count":0,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/5372\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media\/3446"}],"wp:attachment":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media?parent=5372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/categories?post=5372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/tags?post=5372"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/ppma_author?post=5372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}